Canada markets close in 3 hours 9 minutes

Myriad Genetics, Inc. (MYGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
31.95-0.68 (-2.08%)
As of 12:49PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close32.63
Bid31.92 x 1800
Ask31.94 x 800
Day's Range31.86 - 32.90
52 Week Range12.22 - 36.95
Avg. Volume428,298
Market Cap2.494B
Beta (5Y Monthly)1.59
PE Ratio (TTM)121.95
EPS (TTM)0.26
Earnings DateNov. 08, 2021 - Nov. 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est30.13
  • GlobeNewswire

    Myriad Genetics Names Pamela Wong as Chief Legal Officer

    New legal leader brings healthcare expertise from Quest Diagnostics and experience at major global law firmsSALT LAKE CITY, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of Pamela Wong as its new Chief Legal Officer. In her role, she is responsible for leading the company’s legal function, including support and counsel for all legal affairs, intellectual property, patent protection, merg

  • GlobeNewswire

    Americans’ anxiety impacted by the ongoing pandemic, yet 1 in 5 say they won’t seek treatment according to the GeneSight® Mental Health Monitor nationwide survey

    Figure 1: Among those who say they would not seek treatment Things that would lead a person to seek treatment for anxiety SALT LAKE CITY, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Many Americans are experiencing anxiety symptoms as a result of the pandemic. Yet, one in five say they won’t seek treatment for mental health conditions and others say they won’t get help until these symptoms take a toll in their lives. Nearly half (46%) of all respondents rated their anxiety symptoms as moderate to severe ov

  • Zacks

    Here's Why You Should Retain Myriad Genetics (MYGN) for Now

    Investors are optimistic about Myriad Genetics (MYGN) owing to strong testing volume growth and notable product launches.